[ Clinicians Main Page ] [ V Book Sidebars ] [ V Book Endnotes ] [ Recent Journal References ]

Complete Endnotes from The V Book

[ Chapters 1-4 ] [ Chapters 5-7 ] [ Chapters 8-10 ] [ Chapters 11-13 ]
[ Chapters 14-15 ] [ Chapters 16-17 ] [ Chapters 18-19 ] [ Chapters 20-22 ]

Key To Journal Abbreviations

If you're interested in doing further research, the following is a list of medical journals I have cited in this text along with their abbreviations for easy reference. Some of these journals can be accessed for free online at the websites I've provided below (others require a paid subscription).

Chapter 11: BV

1. D. J. Lash, A. G. Tagumpay, Diagnosis and treatment of vaginitis, The Female Patient 1998 May:23:73–93.
2. J. Sobel, Bacterial vaginosis: therapeutic dilemmas, Infect in Med 1990:5:24–30.
3. Ibid.
4. H. L. Gardner, C. D. Dukes, Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified "nonspecific" vaginitis, Am J Obstet Gynecol 1955:69:962.
5. Sobel, Bacterial vaginosis.
6. S. J. Klebanoff, S. L. Hillier, D. A. Eschenbach, et al., Control of the microbial flora of the vagina by H2O2-generating lactobacilli, J Infect Dis 1991:164:94–100.
7. D. A. Eschenbach, Bacterial vaginosis: emphasis on upper genital tract complications, Obstet Gynecol Clin North Am 1989:16:593–610.
8. D. Avonts, M. Sercu, P. Heyerick, et al., Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study, Sex Transm Dis 1990:17:23.
9. L. V. H. Hill, J. A. Embil, Vaginitis: current microbiologic and clinical concepts, Can Med Assoc J 1986:134:321–31.
10. S. E. Hawes, S. L. Hillier, J. Benedetti, et al., Hydrogen peroxide–producing lactobacilli and acquisition of vaginal infection, J Infect Dis 1996:174:1058–63.
11. S. L. Hillier, The prevalence of bacterial vaginosis in sexually inexperienced women, sexually inactive women and women having one or more sexual partners, paper presented at the Infectious Diseases Society of Obstetrics and Gynecology Annual Scientific Meeting, August 5–8, 1998; R. C. Bump, W. J. Buesching, Bacterial vaginosis in virginal and sexually active females: evidence against exclusive sexual transmission, Am J Obstet Gynecol 1988:158:935–39.
12. M. Haukkamaa, P. Stranden, H. Jousimses-Somer, et al., Bacterial flora of the cervix in women using different methods of contraception, Am J Obstet Gynecol 1986:154:520–24.
13. J. L. Thomason, S. M. Gelbert, L. M. Wilcoski, et al., Proline aminopeptidase activity as a rapid diagnostic test to confirm bacterial vaginosis, Obstet Gynecol 1988:171:607–11.
14. P. Meis, R. Goldenberg, J. Iams, et al., Vaginal infections and spontaneous preterm birth, Am J Obstet Gynecol 1995:172:410.
15. C. Stevens-Simon, J. Jamison, J. A. McGregor, J. M. Douglas, Racial variation in vaginal pH among healthy sexually active adolescents, Sex Trans Dis 1994:21:168–72.
16. Hawes et al., Hydrogen peroxide–producing lactobacilli.
17. G. H. Eltabbakh, G. D. Eltabbakh, F. F. Broekhuizen, et al., Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women, Obstet Gynecol 1995:85:499–503; M. A. Byrne, M. J. Turner, M. Griffiths, et al., Evidence that patients presenting with dyskaryotic cervical smears should be screened for genital-tract infections other than human papillomavirus infection, Eur J Obstet Gynecol Reprod Biol 1991:41:129–33.
18. J. Paavonen, K. Teisala, P. K. Heinonen, et al., Microbiological and histopathological findings in acute pelvic inflammatory disease, Br J Obstet Gynaecol 1987:94:454–60; S. Faro, M. Martens, M. Macato, et al., Vaginal flora and pelvic inflammatory disease, Am J Obstet Gynecol 1993:169(2S):470–74.
19. M. G. Gravett, D. Hammel, D. A. Eschenbach, et al., Preterm labor associated with subclinical amniotic fluid infection with bacterial vaginosis, Obstet Gynecol 1986:67:229–37; J. Martius, M. A. Krohn, S. L. Hillier, et al., Relationships of vaginal Lactobacillus species, cervical chlamydia trachomatis, and bacterial vaginosis to preterm birth, Obstet Gynecol 1988:76:89–95; T. Kurki, A. Sivonen, O. V. Renkonen, et al., Bacterial vaginosis in early pregnancy and pregnancy outcome, Obstet Gynecol 1992:80:173–77.
20. J. A. McGregor, D. Lawellin, A. Franco-Buff, et al., Protease production by microorganisms associated with reproductive tract infection, Am J Obstet Gynecol 1986:154:109–14.
21. W. J. Morales, S. Schorr, J. Albritton, Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study, Am J Obstet Gynecol 1994:171(2):345–47; J. C. Hauth, R. L. Goldenberg, W. W. Andrews, M. B. Dubard, et al., Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis, N Engl J Med 1995:333(26):1732–36.
22. H. M. McDonald, J. A. O'Loughlin, R. Vigeswaran, et al., Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo-controlled trial, Br J Obstet Gynaecol 1997:104(12):1338–40.
23. M. R. Joesoef, S. L. Hillier, G. Wiknjosastro, H. Sumampouw, et al., Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight, Am J Obstet Gynecol 1995:173(5):1527–31; J. A. McGregor, J. I. French, W. Jones, et al., Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream, Am J Obstet Gynecol 1994:170(4):1048–59.
24. J. Swedberg, J. F. Steiner, F. Deiss, et al., Comparison of single-dose vs. one-week course of metronidazole for symptomatic bacterial vaginosis, JAMA 1985:254:1046.
25. Sobel, Bacterial vaginosis.
26. S. L. Hillier, address sponsored by 3M Pharmaceuticals, February 1999, Boston.
27. Ibid.
28. Ibid.
29. P. Burtin, A. Taddio, O. Ariburnu, et al., Safety of metronidazole in pregnancy: a meta-analysis, Am J Obstet Gynecol 1995:172:525–29.
30. Joesoef et al., Intravaginal clindamycin cream.
31. Hillier, 1999 address.

Chapter 12: Trich

1. F. G. Bowden, G. P. Garnett, Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions, Sexually Transmitted Infections 2000:76(4):248.
2. H. L. Kent, Epidemiology of vaginitis, Am J Obstet Gynecol 1991:165(4):1168–79.
3. A. Donne, Animacules observés dans les matières purulentes et le produit des secretions des organes genitaux de l'homme et de la femme, C R Acad Sci (III) 1836:3:385–86.
4. O. Hoehne, Trichomonas vaginalis als haufiger erregar einer typischen colpitis prurlenta, Zentralbl Gynakol 1916:40:4–14; G. Johnson, R. E. Trussell, Experimental basis for the chemotherapy of Trichomonas vaginalis, Proc Soc Exp Biol Med 1943:54:245–49.
5. C. Cosar, L. Julou, Activité de l'(hydroxy-2-ethyl)-1-methyl-2-nitro-5-imidazole (R.P. 8823) vis-à-vis des infections experimentales a Trichomonas vaginalis, Ann Inst Pasteur Microbiol 1959:96:238–41.
6. R. A. Underhill, J. Peck, Causes of therapy failure after treatment of T. vaginalis, Br J Clin Pract 1974:28:134.
7. M. F. Rein, M. Muller, Trichomonas vaginalis, in Sexually Transmitted Diseases, K. K. Holmes, P.-A. Mardh, P. F. Sparling, P. J. Weisner, eds. (New York: McGraw-Hill, 1984), 525–36.
8. D. A. Eschenbach, Vaginal infection, Clin Obstet Gynecol 1983:26:186–202.
9. L. G. Keith, J. Friberg, N. Fullan, G. S. Berger, The possible role of Trichomonas vaginalis as a vector for the spread of other pathogens, Int J Fertil 1986:31:272–77.
10. M. R. Spence, Trichomoniasis, Contemp Ob/Gyn 1992 Nov:132–41.
11. A. Fouts, S. Kraus, Trichomonas vaginalis: re-evaluation of its clinical presentation and laboratory diagnosis, J Infect Dis 1980:141:137–43.
12. J. G. Lossick, Treatment of Trichomonas vaginalis infections, Rev Infect Dis 1982:4(suppl):801–18.
13. C. H. Livengood, J. G. Lossick, Resolution of resistant vaginal trichomonas associated with the use of intravaginal nonoxynol-9, Obstet Gynecol 1991:78:954–56.
14. CDC, Sexually transmitted disease treatment guidelines, MMWR 1997:46:72–73.
15. B. D. Reed, A. Eyler, Vaginal infections: diagnosis and management, Am Fam Phys 1993:47(8):1805–16.
16. CDC, Sexually transmitted disease treatment guidelines.

Chapter 13: Vag Itch, Continued

1. M. K. Beard, Atrophic vaginitis: can it be prevented as well as treated? Postgrad Med 1992:91:257–60.
2. A. Miodrag, P. Ekelund, R. Burton, C. M. Castleden, Tamoxifen and partial oestrogen agonism in postmenopausal women, Age and Ageing 1991:20:52–54.
3. Ibid.
4. M. Taylor, Alternatives to conventional hormone replacement, Menopausal Medicine 1998:6:1–6.
5. S. R. Davis, A. L. Murkies, G. Wilcox, Phytoestrogens in clinical practice, Int Med 1998:1:27–34.
6. M. C. Roberts, S. L. Hillier, F. D. Schoenknecht, et al., Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital secretions, J Infect Dis 1985:152:74.
7. J. L. Thomason, P. C. Schreckenberger, W. N. Spellacy, et al., Clinical and microbiological characterization of patients with nonspecific vaginosis associated with mobile, curved anaerobic rods, J Infect Dis 1983:148:817.
8. Ibid.
9. J. K. Oates, D. Rowen, Desquamative inflammatory vaginitis: a review, Genitourin Med 1990:66:725–29; L. A. Gray, M. L. Barnes, Vaginitis in women: diagnosis and treatment, Am J Obstet Gynecol 1965:92:125–27; H. L. Gardner, Desquamative inflammatory vaginitis: a newly defined entity, Am J Obstet Gynecol 1968:102:1102–5.
10. P. Lynch, Desquamative inflammatory vaginitis with oral lichen planus, presented at Second International Congress of the International Society for the Study of Vulvar Disease (Key Biscayne, Florida), E. G. Friedrich, W. E. Josey, eds.; M. Pelisse, D. Leibowitch, D. Sedel, J. Hewitt, Un nouveau syndrome vulvo-vagino-gingival: lichen plan erosive pluriuqueux, Acta Derm Venereol (Paris) 1982:109:797–98; J. Hewitt, M. Pelisse, D. Lessan-Leibowitch, D. Sedel, et al., Le syndrome vulvo-vaginal-gingival, Rev Stomatol Chir Maxillofac 1985:86:57–65; L. Edwards, E. G. Friedrich Jr., Desquamative vaginitis: lichen planus in disguise, Obstet Gynecol 1988:71:832–36.
11. J. D. Sobel, Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy, Obstet Gynecol 1994:171(5):1215–20.
12. L. J. Cibley, L. J. Cibley, Cytolytic vaginosis, Am J Obstet Gynecol 1991:165:1245–49.
13. C. Marty-Taysset, F. de la Torre, J. Garel, Increased production of hydrogen peroxide by lactobacillus delbruecki subspecies bulgaricus upon aeration: involvement of an NADH oxidase in oxidative stress, Applied and Environmental Microbiology 2000(Jan):66(1):262.